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Abstract
Objective: The objective of the present study was to investigate associations between
sugar intake and overweight using dietary biomarkers in the Norfolk cohort of the
European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk).
Design: Prospective cohort study.
Setting: EPIC-Norfolk in the UK, recruitment between 1993 and 1997.
Subjects: Men and women (n 1734) aged 39–77 years. Sucrose intake was assessed
using 7 d diet diaries. Baseline spot urine samples were analysed for sucrose by
GC-MS. Sucrose concentration adjusted by speciﬁc gravity was used as a biomarker
for intake. Regression analyses were used to investigate associations between
sucrose intake and risk of BMI>25·0 kg/m2 after three years of follow-up.
Results: After three years of follow-up, mean BMI was 26·8 kg/m2. Self-reported
sucrose intake was signiﬁcantly positively associated with the biomarker. Associations
between the biomarker and BMI were positive (β=0·25; 95 % CI 0·08, 0·43), while
they were inverse when using self-reported dietary data (β=−1·40; 95% CI −1·81,
−0·99). The age- and sex-adjusted OR for BMI>25·0 kg/m2 in participants in the ﬁfth v.
ﬁrst quintile was 1·54 (95% CI 1·12, 2·12; Ptrend=0·003) when using biomarker and 0·56
(95% CI 0·40, 0·77; Ptrend<0·001) with self-reported dietary data.
Conclusions: Our results suggest that sucrose measured by objective biomarker
but not self-reported sucrose intake is positively associated with BMI. Future
studies should consider the use of objective biomarkers of sucrose intake.
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Obesity and overweight are associated with increased risk
for a number of chronic diseases, such as cancer(1), CVD(2)
and type 2 diabetes. However, although energy balance is
clearly central, there remains uncertainty about the role of
speciﬁc dietary factors. While public perception suggests that
the intake of sugar is associated with an increased risk of
obesity and thus overweight people consume more sugar(3),
data from observational studies are inconsistent and weight
increase or markers of obesity are associated mainly with the
intake of sugar-sweetened beverages but not, or only to a
small extent, with the total intake of sugar or sucrose(4,5).
Indeed, the US Institute of Medicine reported an inverse
association between sugar intake and BMI in adults(6). The
European Food Safety Authority based its scientiﬁc opinion
on these ﬁndings(7), although it omitted acknowledging that
the Institute of Medicine considers the ﬁnding to be
explained mainly by under-reporting. Under-reporting of
diet has been found to be more prevalent among women
and obese people(8–10) and it is mainly simple sugars and
between-meal snacks that are most commonly under-
reported(11). This makes it difﬁcult to interpret the inverse
associations between reported sugar intake and BMI and to
provide reliable recommendations to the public.
Urinary sugars, in particular sucrose and fructose, have
been investigated and developed as dietary biomarkers of
total sugar intake(12–16). If 24 h urine collections are available,
P
u
b
lic
H
ea
lt
h
N
u
tr
it
io
n
Public Health Nutrition: page 1 of 10 doi:10.1017/S1368980015000300
*Corresponding author: Email g.g.kuhnle@reading.ac.uk
© The Authors 2015. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://
creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original
work is properly cited.
sucrose and fructose measured in 24 h urine can be used as
predictive biomarkers of total sugar intake(16). Given the
sugars biomarker is a short-term measure of intake, when
measured in spot urine its value will be associated with a
certain amount of random error dependent on the timing of
the spot urine collection. This error will be expected to
attenuate the association between true intake and the bio-
marker. Nevertheless, earlier work showed sucrose in partial
collections to be signiﬁcantly correlated with sucrose
intake(13). Previously, we have applied this biomarker to spot
urine samples and investigated the association between
sugar intake and obesity in a cross-sectional case–control
study design in a sub-sample of the Norfolk cohort of the
European Prospective Investigation into Cancer and Nutri-
tion (EPIC-Norfolk), which only included normal weight
(BMI≤25·0 kg/m2) and obese (BMI ≥ 30·0 kg/m2) partici-
pants(3). In that study we found a signiﬁcant positive asso-
ciation between the biomarker and obesity (OR=2·44; 95%
CI 1·54, 3·86 for the bottom v. top quintile).
Here, we prospectively investigated the association
between sucrose intake and risk of overweight and obesity
in a sample of the EPIC-Norfolk cohort study using urinary
sugar biomarkers and self-reported dietary data.
Materials and methods
Study population
Between 1993 and 1997, approximately 77 630 healthy men
and women were invited to participate in the EPIC-Norfolk
study through thirty-ﬁve medical practices in Norfolk(17,18);
25 639 participants, aged between 39 and 79 years, agreed to
participate and attended the ﬁrst health examination. Diet
was assessed by 7 d diet diary (7DD) and a 130-item semi-
quantitative FFQ. The ﬁrst day of the diary was completed as
a 24 h recall (24HDR) with a trained interviewer, whereas the
remainder was completed during subsequent days by the
participants at home. Diary data were processed using the in-
house dietary assessment software DINER (Data Into Nutri-
ents for Epidemiological Research)(19); data were checked
and calculated using DINERMO, the software used to pro-
cess data entered by DINER(20). FFQ data were analysed
using the in-house program, FETA (FFQ EPIC Tool for
Analysis), to calculate the nutrient content(21). Health and
lifestyle characteristics were assessed by a questionnaire.
Physical activity, representing occupational and leisure
activity, was assessed using a validated questionnaire(22),
using four categorical variables (inactive, moderately inac-
tive, moderately active and active). Height and weight
measurements were collected following a standardised pro-
tocol as part of a health check conducted by trained research
nurses(23). Spot urine samples were collected at baseline
during the study visit (day 2 of the diary) and stored at −20°C
without preservatives. The study received ethical approval
by the Norwich District Health Authority Ethics Committee
and all participants gave signed informed consent.
Participants were invited back for a second health
examination after three years of follow-up from 1997 to
2000 and 15 786 participants attended. A health and life-
style questionnaire was completed before the health
examination. At the health examination, the protocol of
the ﬁrst health examination was repeated and data on
height, weight and waist circumference (WC) were col-
lected by trained nurses. The anthropometric measures
collected at the second health examination were used as
outcome measures in the analysis.
Sample selection and missing data
Baseline spot urine samples (n 5993) were selected
randomly from the storage facility. While this selection was
random, the samples are not necessarily a representative
selection of the cohort. Co-variables (sex, dietary data and
speciﬁc gravity) were missing for 155 participants and end
points (anthropometric data) were missing for a further 2467
who did not attend the second health examination. Urinary
sucrose analyses failed for 195 participants and results were
outside the calibration range for 1442 participants, leaving a
total sample size of 1734 (see Fig. 1 for details). For sensi-
tivity analyses, sucrose concentrations below and above the
limits of quantiﬁcation (<5·0 µM or >500 µM) were imputed
with 4·9 µM and 500·1 µM, respectively.
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Fig. 1 Study population and sample size (2HC, second health
check; LLOQ, lower limit of quantification; ULOQ, upper limit of
quantification)
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Analytical method
Urinary sucrose and fructose were analysed using a
modiﬁed version of the method described previously(24).
Urine aliquots (200 µl) were mixed with 50 µl internal
standard solution ([13C6]fructose and [
13C12]sucrose, 100 µM
in water; CK Isotopes, Ibstock, UK) and 800 µl cold
acetonitrile was added to precipitate proteins. Samples
were processed using a Hamilton Star (HAMILTON
Robotics Ltd, Birmingham, UK) robot. The samples were
mixed and centrifuged for 30 min at 14 000g, then 500 µl of
the supernatant was transferred into a silanised glass vial
and dried under reduced pressure. The samples were
then derivatised as described previously(24,25). Brieﬂy, the
samples were reconstituted in 30 µl methoxyamine
hydrochloride (20 mg/ml in dry pyridine; Sigma-Aldrich,
Gillingham, UK), mixed and incubated at room tempera-
ture for 30 min. After 16 h at room temperature, 30 µl
N-methyl-N-trimethylsilyl-triﬂuoroacetamide containing 1 %
trimethylchlorosilane (Sigma-Aldrich) was added to each
sample and incubated for 30min at 75°C. The derivatised
samples were diluted with 540 µl dry acetonitrile.
Samples were then analysed with a Trace GC Ultra and
a Trace DSQ quadrupole mass spectrometer (Thermo-
Electron, Hemel Hempstead, UK). The derivatised sample
was injected with a 1:10 split on to a 30 m× 0·25 mm i.d.,
5 % phenylpolysilphenylene-siloxane column with a
chemically bonded 25mm TR-5MS stationary phase
(ThermoElectron). The oven temperature was kept at 60°C
for 2 min and then increased by 58°C/min to 310°C. The
carrier gas was helium (ﬂow rate 1·2ml/min). The mass
spectrometer (transfer line temperature: 250°C; ion source
temperature: 275°C; electron beam: 70 eV) was operated
in full scan mode (50–650m/z; 3 scans/s) and compounds
were identiﬁed by their retention time and characteristic
fragments.
Samples were quantiﬁed using the peak area ratio
(analyte:internal standard) using an eight-point calibration
line with samples prepared in water (concentration in
µM: 5, 10, 15, 25, 50, 75, 100 and 150). The difference
between back-calculated and actual concentrations was
always less than 5 %. Samples with a concentration outside
the calibration range were diluted and re-analysed.
Fructose was quantiﬁed using the sum of the peak area of
the two epimers of the analyte and the internal standard.
Quality control samples were prepared by adding
known amounts of sucrose and fructose to spot urine
samples and including at least three (with low, medium
and high concentrations) in each analytical batch. Sup-
plemental Table 1 (see online supplementary material)
shows the reproducibility of the method for urinary
sucrose and fructose at different concentrations. Urinary
sucrose and fructose concentration remained stable for at
least 7 d at 4°C.
The STROBE (Strengthening the Reporting of Observa-
tional Studies in Epidemiology) checklist for cohort
studies(26) has been completed for the present study.
Data analysis
For data analyses, samples with urinary sucrose con-
centrations outside the acceptable quantiﬁcation range
were excluded. Based on the data shown in Supplemental
Table 1, the acceptable range for sucrose was 5 µM to
500 µM (1·7mg/l to 171 mg/l) and 20 µM to 500 µM (3·6mg/l
to 90 mg/l) for fructose. Data on urinary fructose were
used in the sensitivity analysis only, whereas the main
analysis was conducted using urinary sucrose as a bio-
marker for sucrose intake. Concentration of sucrose in
urine was expressed relative to speciﬁc gravity to adjust
for urine concentration. Creatinine could not be used,
given the highly signiﬁcant association between urinary
creatinine and BMI (ρ= 0·15; P< 0·0001).
The distributions of the biomarker (urinary sucrose) and
self-reported sugar intake were skewed and therefore all
analyses with continuous data were conducted with log-
transformed data. Both sex-speciﬁc and sex-adjusted
analyses were conducted. 7DD sucrose intake was
adjusted for energy intake using the nutrient density
method (g/MJ). The association of self-reported energy-
adjusted sucrose intake or sucrose biomarker with BMI
and WC at the second health examination was assessed
using linear regression models adjusted for age and sex;
for WC, the model was also adjusted for height at the
second health check. We report β coefﬁcients for the
regression of BMI or WC v. log-transformed biomarker or
self-reported energy-adjusted sucrose intake. Participants
were divided into quintiles by urinary biomarker (sucrose
adjusted by speciﬁc gravity) and dietary intake (self-
reported sucrose intake, 7DD). Odds ratios and 95 %
conﬁdence intervals for BMI> 25·0 kg/m2 after three years
of follow-up were estimated using unconditional logistic
regression in age- and sex-adjusted models. Tests for
linear trend were conducted by treating quintiles as
continuous variables.
We also included biomarker (log-transformed) and self-
reported intake (7DD, energy-adjusted, log-transformed)
in the same linear regression model to calculate adjusted
means of BMI (additionally adjusted for age) and WC
(additionally adjusted for age and height) after three years
of follow-up.
Statistical analyses were conducted with the statistical
software package Stata version 11·2 and R(27). The
P values for statistical tests were two-tailed and considered
statistically signiﬁcant at a level of less than 0·05.
Results
Study population
Spot urine samples were analysed from a selection of 5986
participants (2578 men, 43 %; 3408 women, 57 %) of EPIC-
Norfolk. Co-variables and end points were available for
3371 participants (1338 men, 41 %; 1983 women, 59 %;
Fig. 1). Urinary sucrose concentration was outside the
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calibration range (5 µM to 500 µM) or could not be detected
due to analytical problems in 1637 participants, leaving
1734 participants (797 men, 46 %; 937 women, 54 %) for
whom biomarker data were available. After three years of
follow-up, the mean BMI increased from 26·2 (95 % CI
26·0, 26·4) kg/m2 at baseline to (95 % CI 26·6, 27·0)
26·8 kg/m2, and 35 %, 48 % and 17 % of the participants
were normal weight, overweight and obese, respectively.
The mean WC was 96·9 (95 % CI 96·2, 97·6) cm in men and
82·1 (95 % CI 81·5, 82·8) cm in women.
We compared urinary sucrose, adjusted by speciﬁc
gravity, as a biomarker for sucrose intake with energy-
adjusted, self-reported 7DD sucrose intake. Supplemental
Table 2 gives a summary of the baseline characteristics of
study participants, divided into quintiles by biomarker and
self-reported intake, respectively (more details are shown
in Supplemental Tables 3 and 4, see online supplementary
material). Independent of the classiﬁcation method used
(biomarker or energy-adjusted self-reported intake), age,
energy and sucrose intake (g/d) increased across quintiles.
The proportion of dietary sucrose to total dietary sugars
also increased from the bottom to the top quintile, with a
larger range being observed when using self-reported
dietary data. However, while there were more women in
the bottom quintile of biomarker and more men in the top
one, this relationship was reversed when using self-
reported dietary data. Mean BMI measured at both
baseline and the second health check increased across
quintiles for the biomarker, while it decreased across
quintiles for self-reported sucrose. Similar observations
were made for WC measured at the second health check.
Association between intake and biomarker
In sex-combined analysis, energy-adjusted intake of
sucrose (7DD) was signiﬁcantly associated with the bio-
marker (β= 0·078; 95 % CI 0·059, 0·097) and this associa-
tion did not change materially when adjusted for age and
sex. In men, the association was considerably stronger
(β= 0·108; 95 % CI 0·079, 0·138) than in women (β= 0·060;
95 % CI 0·035, 0·085). This association was also signiﬁcant
for non-energy adjusted sucrose intake (β= 0·188; 95 % CI
0·144, 0·232; per 25 g/d increase in sucrose intake) and
remained stable after adjusting for age and sex. As above,
the association was stronger in men (β= 0·231; 95 % CI
0·155, 0·306; per 25 g/d increase in sucrose intake) than in
women (β= 0·094; 95 % CI 0·045, 0·143; per 25 g/d
increase in sucrose intake).
The relationship between biomarker and self-reported
intake, expressed as the ratio of biomarker to energy-
adjusted sucrose intake, was positively associated with
baseline and follow-up BMI (Fig. 2). Indeed, there was a
signiﬁcant positive association with BMI at follow-up
(β= 0·04; 95 % CI 0·03, 0·05) in an unadjusted model and
after adjusting for age and sex (β= 0·04; 95 % CI 0·02,
0·05). The median ratio was approximately 50 % higher in
overweight and obese participants when compared with
normal-weight participants.
Associations between self-reported sucrose intake,
biomarker, BMI and waist circumference
Table 1 shows the associations between sucrose, deter-
mined either by biomarker or 7DD, and BMI and WC at
follow-up. The data show a positive association for the
biomarker with BMI and WC, but an inverse association
for both energy-adjusted (β= −1·40; 95 % CI −1·81, −0·99)
and absolute (β= −1·38; 95 % CI −1·72, −1·04) self-
reported intake (adjusted for age and sex). These asso-
ciations were statistically signiﬁcant for women with both
biomarker and 7DD data, but only with 7DD data for men.
When including biomarker and self-reported dietary data
in the same model, the associations were strengthened
and remained in opposite directions (biomarker, log-
transformed: β= 0·38; 95 % CI 0·21, 0·55; dietary data,
energy-adjusted and log-transformed: β=− 1·57; 95 % CI
−1·99, −1·16; Table 1). Similar relationships were found
after stratiﬁcation by sex (data not shown).
Associations between self-reported sucrose intake,
biomarker and risk of being overweight
There were signiﬁcant associations between the biomarker
and risk of being overweight or obese after three years of
follow-up (Table 2, Fig. 3) with an OR of 1·54 (95% CI 1·12,
2·12; P= 0·008) between the top and bottom quintile and a
signiﬁcant trend (P=0·003) across quintiles. Stratiﬁcation by
sex showed a marginally non-signiﬁcant trend (P=0·054) in
men and a signiﬁcant (P=0·02) trend in women. Con-
versely, there was an inverse association when using self-
reported intake with an OR of 0·56 (95% CI 0·40, 0·77;
P<0·0001) and also a signiﬁcant trend (P<0·0001). After
stratiﬁcation for sex, the trend remained signiﬁcant in both
men and women. When using the biomarker as a con-
tinuous variable, the OR for BMI>25·0 kg/m2 was 1·16
(95% CI 1·05, 1·27) per log increase. Conversely, the OR
was 0·60 (95% CI 0·47, 0·77) when using self-reported
dietary data. An analysis of the association between intake
and risk of being overweight or obese at baseline gave
similar results in the sex-adjusted model (see online sup-
plementary material, Supplemental Table 5).
The ratio of urinary sucrose to fructose concentration
has been used previously as a biomarker of sugar intake in
relation to risk of being overweight(3). Applying this bio-
marker in the current study reduced the sample size, given
there were fewer available samples with both sucrose and
fructose values within the acceptable analytical range, to
1238 participants (578 men, 47 %; 660 women, 53 %). The
associations observed with urinary sucrose to fructose
ratio were not materially different from those observed
with speciﬁc-gravity adjusted sucrose concentration in
urine (see online supplementary material, Supplemental
Table 6).
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Comparison of different dietary assessment
instruments (7 d diet diary, 24 h recall and FFQ)
Energy-adjusted sucrose intake by 24HDR (ﬁrst day of
7DD) was signiﬁcantly associated with estimates from
7DD (β= 1·08; 95 % CI 1·04, 1·13) and the biomarker
(β= 0·11; 95 % CI 0·08, 0·14; age- and sex-adjusted model).
The latter association was stronger in men than in women
(data not shown).
FFQ-measured sucrose (g/MJ), available for 1685 partici-
pants, was signiﬁcantly associated with sucrose measured by
both 7DD (β=0·70; 95% CI 0·65, 0·75) and 24HDR (β=0·88;
95% CI 0·81, 0·96). The association with the biomarker was
also signiﬁcant (β=0·05; 95% CI 0·04, 0·07; age- and sex-
adjusted model) and stronger in men than in women.
Self-reported sucrose intake, independent of the dietary
assessment instrument used and adjustment for energy
intake, was inversely associated with BMI and WC after
three years of follow-up (Table 3), although the associa-
tions were weakest with data from 24HDR.
Effect of physical activity
The associations observed did not change materially after
including physical activity in the model (see online sup-
plementary material, Supplemental Table 7).
Sensitivity analyses with biomarker data
outside the calibration range
Biomarker data were available for 3176 participants (1297,
41 % men; 1879, 59 % women; see online supplementary
material, Supplemental Table 8 for details), although the
urinary sucrose concentration in 1411 participants was
below and in thirty-one participants was above the limit of
quantiﬁcation. In men, baseline BMI of participants with
urinary sucrose concentration below the limit of quantiﬁ-
cation (n 498; mean BMI= 26·2 kg/m2) was signiﬁcantly
(P= 0·04, t test) lower than that of participants with
sucrose concentration within the calibration range (n 821;
mean BMI= 26·5 kg/m2). No signiﬁcant difference was
observed in women (P= 0·65).
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Fig. 2 Relationship between the biomarker (specific-gravity-adjusted urinary sucrose) and self-reported intake (energy-adjusted
sucrose intake, as assessed by 7 d diet diary (7DD)), expressed as a ratio, and BMI after three years of follow-up among men and
women (n 1734) aged 39–77 years, Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-
Norfolk). Presented are box-and whisker plots in which the bottom and top of the box represents the 25th and 75th percentile,
respectively (the interquartile range), the line within the box represents the median and the bottom and top of the whisker represents
the minimum and maximum value, respectively, of log-transformed ratio of biomarker to 7DD for three BMI classes (normal weight
(left), overweight (middle) and obese (right)) at the second health check (2HC); and a least-square linear model with 95%
confidence interval ( )
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Table 1 Associations between sucrose intake (by biomarker or 7 d diet diary (7DD)), BMI and waist circumference (WC) after three years of follow-up at the second health check among men and
women (n 1734) aged 39–77 years, Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk)
Sucrose intake and biomarker in separate models Sucrose intake and biomarker in the same model
BMI (kg/m2) adjusted for age WC (cm) adjusted for age and height BMI (kg/m2) adjusted for age WC (cm) adjusted for age and height
β 95% CI P β 95% CI P β 95% CI P β 95% CI P
Men (n 797)
Biomarker* 0·09 −0·13, 0·31 0·442 0·42 −0·22, 1·06 0·195 0·22 0·00, 0·45 0·052 0·82 0·17, 1·46 0·013
Intake† −1·18 −1·67, −0·69 <0·001 −3·35 −4·78, −1·93 <0·001 −1·30 −1·81, −0·79 <0·001 −3·79 −5·25, −2·33 <0·001
Women (n 937)
Biomarker* 0·40 0·14, 0·65 0·002 0·85 0·24, 1·46 0·007 0·50 0·25, 0·76 <0·001 1·12 0·52, 1·73 <0·001
Intake† −1·60 −2·25, −0·96 <0·001 −4·19 −5·75, −2·64 <0·001 −1·80 −2·45, −1·15 <0·001 −4·63 −6·19, −3·07 <0·001
Sex-adjusted (n 1734)
Biomarker* 0·25 0·08, 0·43 0·004 – – 0·38 0·21, 0·55 <0·001 – –
Intake† −1·40 −1·81, −0·99 <0·001 – – −1·57 −1·99, 1·16 <0·001 – –
Data are shown with biomarker and intake in separate models as well as in the same model. Regression coefficients β and 95% confidence intervals were determined by linear regression. Biomarker and intake data were
log-transformed before analysis.
*Urinary sucrose, adjusted by specific gravity.
†7DD sucrose intake, energy-adjusted (g/MJ).
Table 2 Associations between sucrose intake and risk of being overweight or obese after three years of follow-up at the second health check among men and women (n 1734) aged 39–77 years,
Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk)
Men (n 797) Women (n 937) All (n 1734)
Overweight* Overweight* Overweight*
n % OR 95% CI P n % OR 95% CI P n % OR 95% CI P
Urinary sucrose, adjusted by specific gravity
Q1 105 66 1·00 Ref. – 106 56 1·00 Ref. – 201 58 1·00 Ref. –
Q2 114 72 1·31 0·82, 2·11 0·263 98 52 0·84 0·56, 1·27 0·416 216 62 1·15 0·84, 1·56 0·384
Q3 115 72 1·33 0·83, 2·14 0·238 105 56 0·96 0·64, 1·45 0·857 225 65 1·26 0·92, 1·71 0·149
Q4 119 75 1·54 0·95, 2·50 0·082 123 66 1·45 0·96, 2·21 0·080 237 68 1·43 1·05, 1·96 0·025
Q5 120 75 1·57 0·96, 2·57 0·070 119 63 1·33 0·88, 2·02 0·180 245 71 1·54 1·12, 2·12 0·008
Trend – 1·11 1·00, 1·25 0·054 – 1·12 1·02, 1·23 0·020 – 1·12 1·04, 1·20 0·003
Sucrose intake, 7DD energy-adjusted
Q1 128 80 1·00 Ref. – 120 64 1·00 Ref. – 255 73 1·00 Ref. –
Q2 123 77 0·84 0·49, 1·44 0·525 117 63 0·92 0·61, 1·41 0·710 236 68 0·77 0·56, 1·08 0·129
Q3 106 66 0·48 0·29, 0·80 0·005 107 57 0·73 0·48, 1·11 0·146 209 60 0·56 0·41, 0·78 0·001
Q4 107 67 0·50 0·30, 0·84 0·008 103 55 0·68 0·45, 1·03 0·068 212 61 0·58 0·42, 0·80 0·001
Q5 109 69 0·53 0·32, 0·89 0·015 104 56 0·69 0·45, 1·04 0·076 212 61 0·56 0·40, 0·77 <0·001
Trend – 0·84 0·75, 0·94 0·003 – 0·90 0·82, 0·99 0·026 – 0·87 0·81, 0·93 <0·001
7DD, 7 d diet diary; Q1, quintile 1 (lowest); Q2, quintile 2; Q3, quintile 3; Q4, quintile 4; Q5, quintile 5 (highest); Ref., referent category.
Odds ratios and 95% confidence intervals were determined by logistic regression, adjusted for age and sex.
*Second health check, BMI> 25·0 kg/m2.
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After imputation of data below and above the calibra-
tion range with 4·9 µM and 500·1 µM respectively, the
urinary sucrose biomarker was signiﬁcantly positively
associated with self-reported sucrose intake (β= 0·051;
95 % CI 0·039, 0·063). The associations with BMI at follow-
up (β= 0·17; 95 % CI 0·06, 0·27; adjusted for age and sex)
and WC at follow-up up (men: β= 0·55; 95 % CI 0·15, 0·95;
women: β= 0·54; 95 % CI 0·15, 0·93; both adjusted for age)
were also signiﬁcant. The association between the bio-
marker and risk of being overweight was also signiﬁcant,
with an OR of 1·08 (95 % CI 1·01, 1·14; adjusted for age
and sex) per log increase of biomarker; the OR when
using dietary data was 0·61 (95 % CI 0·51, 0·72; adjusted
for age and sex).
Sensitivity analysis with gastric ulcer status
A diagnosis of gastric ulcer was reported by sixty-seven
participants (thirty-seven men, thirty women) and they
did not differ signiﬁcantly in age and BMI (baseline and
second health check). Urinary sucrose concentration was
signiﬁcantly different in men (two-sided t test with log-
transformed data, geometric mean (SD); gastric ulcer v.
other: 53 (SD 1) µM v. 36 (SD 1) µM; P= 0·04) but not in
women (26 (SD 1) µM v. 27 (SD 1) µM; P= 0·8). Participants
with self-reported gastric ulcer were not equally dis-
tributed across quintiles of biomarker (P= 0·004, χ2 test),
with most participants found in the fourth (n 22), ﬁfth
(n 18) and ﬁrst (n 14) quintiles.
The associations between biomarker and self-reported
energy-adjusted sucrose intake, BMI and WC at the second
health check were not materially different after excluding
participants with self-reported gastric ulcer (see online
supplementary material, Supplemental Table 9). The esti-
mated risk of being overweight or obese after follow-up
was slightly attenuated, yet the results were not materially
different (see online supplementary material, Supple-
mental Table 10).
Discussion
In the present study, we investigated prospectively the risk
of overweight and obesity in relation to sucrose intake
estimated by 7DD and biomarker. Using urinary sucrose
as the measure of sucrose intake, participants in the
highest v. the lowest quintile for sucrose intake had 54 %
greater risk of being overweight or obese. In contrast,
using self-reported sucrose intake measured by 7DD,
those in the highest v. the lowest quintile for self-reported
sucrose intake were at 44 % lower risk of being overweight
or obese.
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Table 3 Comparison of different assessment methods: associations (regression coefficients β and 95% confidence intervals) between
sucrose intake (log-transformed) and BMI and waist circumference (WC) after three years of follow-up among men and women (n 1734)
aged 39–77 years, Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk)
BMI (kg/m2)*,† WC (cm)*,‡
All Men Women
β 95% CI β 95% CI β 95% CI
7DD (adjusted for energy intake) −1·40 −1·81, −0·99 −3·34 −4·77, −1·91 −4·21 −5·77, −2·66
24HDR§ (adjusted for energy intake) −0·78 −1·06, −0·51 −2·31 −3·33, −1·30 −2·14 −3·13, −1·15
FFQ (adjusted for energy intake) −1·32 −1·83, −0·81 −2·74 −4·54, −0·94 −2·52 −4·44, −0·59
7DD −1·38 −1·72, −1·04 −2·80 −4·00, −1·61 −3·85 −5·14, −2·56
24HDR −0·80 −1·04, −0·57 −2·03 −2·92, −1·13 −2·05 −·288, −1·22
FFQ −1·07 −1·42, −0·71 −2·76 −4·03, −1·49 −1·87 −3·19, −0·54
Biomarker|| 0·25 0·08, 0·43 0·43 −0·21, 1·06 0·87 0·26, 1·49
7DD, 7 d diet diary; 24HDR, 24 h recall.
*At second health check.
†Adjusted for age and sex.
‡Adjusted for height and age.
§Among 1685 participants only.
||Urinary sucrose adjusted by specific gravity.
Q1 Q2 Q3 Q4 Q5
0.0
0.5
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Fig. 3 Association between sucrose intake and risk of
overweight or obesity after three years of follow-up using
either dietary data (■, energy-adjusted, as assessed by 7 d
diet diary) or biomarker (●, urinary sucrose, adjusted by
specific gravity) among men and women (n 1734) aged 39–77
years, Norfolk cohort of the European Prospective Investigation
into Cancer and Nutrition (EPIC-Norfolk). Presented are odds
ratios with their 95% confidence intervals represented by vertical
bars (Q1, quintile 1 (lowest); Q2, quintile 2; Q3, quintile 3; Q4,
quintile 4; Q5, quintile 5 (highest))
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Our results show a clear discrepancy in the association
between sucrose intake and the risk of overweight or
obesity depending on the dietary assessment method. The
associations observed with self-reported intake are in
agreement with data from cross-sectional studies pub-
lished previously(3,28), in which a cross-sectional analysis
of 875 participants of EPIC-Norfolk found a strong positive
association between sugar intake and obesity risk when
using the biomarker (trend per quintile, normal weight v.
obese: OR= 1·26; 95 % CI 1·14, 1·40; P< 0·0001)(3).
There are several possible reasons for this apparent
discrepancy. The inverse association between self-
reported sucrose intake and body weight has been used
as a basis for dietary recommendations(7). First the suit-
ability of the biomarker used in the present study needs
consideration: while there is only limited information on
the physiological mechanisms underlying the absorption
and excretion of sucrose, several controlled-feeding stu-
dies have shown a clear dose–response relationship
between sucrose intake and urinary excretion(12–14), which
is independent of BMI(15). This has led to the development
and validation of 24 h urinary sucrose and fructose as a
biomarker for total sugar intake(16). However, 24 h urine
samples are difﬁcult to obtain and are cost-prohibitive in
large observational studies, such as EPIC-Norfolk. Sucrose
concentration in spot urine samples can be used as a
concentration marker(29) in order to rank participants
according to intake. Given that we used spot urine sam-
ples to measure the biomarker, these samples required an
adjustment for urine dilution. We used speciﬁc gravity,
rather than urinary creatinine concentration, which is
commonly used for this purpose. In our participants,
urinary creatinine was highly signiﬁcantly associated with
BMI (P< 0·0001) and therefore would have had a strong
confounding effect on the observed association. In the
previous analysis of EPIC-Norfolk, the ratio of urinary
sucrose to fructose was used to adjust for the dilution
effect in spot urine samples(3). However, while this ratio
was strongly associated with sugar intake and obesity risk,
it is difﬁcult to interpret as urinary fructose concentration
depends not only on fructose but also on sucrose con-
sumption, as sucrose is hydrolysed into glucose and
fructose in vivo. In the present study we have therefore
focused on urinary sucrose only and used urinary speciﬁc
gravity to compensate for the dilution effect, although risk
estimates remained similar when using sucrose:fructose as
a measure of intake. While speciﬁc gravity is also asso-
ciated with BMI, the association was weaker than for
creatinine (ρ= 0·08; P = 0·0004). We could show that
speciﬁc-gravity-adjusted urinary sucrose concentration
was positively, and signiﬁcantly, associated with self-
reported intake from 7DD, 24HDR and FFQ.
Our results indicate that those in the highest category of
sucrose intake as measured by the biomarker had the
highest risk of being overweight or obese after three years of
follow-up. Furthermore, we observed that a combination of
low self-reported sucrose intake and high biomarker was
associated with high BMI and WC. The tendency to under-
report the intake of unhealthy foods and foods with high
sugar content, especially among those who are overweight
and obese(9), may possibly be reason for the observed
inverse association with self-reported intake. The positive
association between BMI and the ratio of biomarker to self-
reported intake suggests that participants with a higher BMI
are more likely to under-report intake. As we have shown
previously, the relationship between dietary and urinary
sucrose is not affected by BMI(15) and therefore does not
explain this observation. There is some evidence suggesting
that an important cause of under-reporting is the failure to
report snack foods consumed between meals(11) and bis-
cuits, cakes, confectionery and other types of snacks
were main contributors to total sucrose intake in EPIC-
Norfolk (Table 4). A recent biomarker-based study detected
substantial measurement error in self-reported sugar intake
assessed by both FFQ and 24HDR, which was greater
in women than men for both dietary assessment
instruments(16).
The strengths of the present study are the use of a
biomarker as a surrogate measure of sucrose intake
besides self-reported intake only, use of 7DD as a more
detailed self-report dietary instrument and the well-
characterised cohort. We also report ﬁndings for FFQ
and 24HDR. However, there were also some limitations:
sensitivity of our method for quantifying sucrose and
fructose in urine was limited, which resulted in a reduced
sample size and the pseudo-random selection of samples.
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Table 4 Main sources of sucrose intake in men (n 797) and women
(n 937) aged 39–77 years, Norfolk cohort of the European Pro-
spective Investigation into Cancer and Nutrition (EPIC-Norfolk),
based on data from 7 d diaries
Mean SD Contribution (%)
Men
Table sugar 16·8 25·3 29
Cake 8·9 9·8 15
Fruits 6·2 5·9 11
Sweet biscuits 3·7 4·9 6
Pudding (milk-based) 2·8 3·6 5
Confectionery (chocolate) 2·8 5·4 5
Breakfast cereals 2·0 3·6 3
Jam and marmalade 1·7 3·8 3
Squash and lemonade 1·5 4·4 3
Pudding (cereal-based) 1·5 3·7 3
Women
Fruits 7·5 5·8 18
Table sugar 6·5 14·1 15
Cake 6·3 6·8 15
Confectionery (chocolate) 2·9 5·0 7
Sweet biscuits 2·8 3·4 7
Pudding (milk-based) 2·3 3·0 5
Yoghurt 1·8 3·2 4
Breakfast cereals 1·6 2·6 4
Confectionery (non-chocolate) 1·4 3·5 3
Juices 1·4 2·3 3
Mean and standard deviation of intake in g/d and percentage contribution to
total sucrose intake.
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Yet, analyses with imputed values for those outside the
calibration range suggest that the reduced concentration
range did not affect the observed associations. We also
used spot urines, rather than 24 h urine collection, to
measure sucrose and fructose. Furthermore, we report
P values without adjustment for multiple testing and this
must be taken into consideration when interpreting
results. There were also some participants with gastric
damage, which can lead to increased permeability of
gastric mucosa for sucrose and increased excretion in
urine(30). However, gastric damage did not affect the
outcome of our analyses.
There is some ambiguity in data from observational
studies investigating associations between sugar intake
and BMI. While sugar-sweetened beverage intake is
clearly associated with an increased BMI(4,5,31), the asso-
ciation is less clear for total sugar intake and sucrose and
some studies report inverse associations. Indeed, recent
guidance by the European Food Safety Authority(7) sug-
gests such an association. In the present study we
observed a clear discrepancy between self-reported
sucrose intake and biomarker-based ﬁndings in the rela-
tionship with BMI, despite correlation between the two
measures of sugar intake. This is consistent with our pre-
vious results(3). These data suggest that the inconsistency
of data on sucrose and obesity may be in part attributed to
misreporting and nutritional biomarkers are important to
understand these associations better.
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